Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation

Diabetes and Metabolism

Volumn 37, Issue 6, 2011, Pages 527-532

  Gin, H ^a   Baudoin, R ^a   Raffaitin, C H ^a   Rigalleau, V ^a   Gonzalez, C ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Diabetes; Diabetic foot; Diabetic foot ulcer risk; Diabetic neuropathy; Sudomotor function; Vibration perception threshold

Indexed keywords

CHLORIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC NEUROPATHY; DISEASE SEVERITY; ELECTROCHEMICAL ANALYSIS; GLUCOSE BLOOD LEVEL; HAND; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; NON INVASIVE MEASUREMENT; PERCEPTIVE THRESHOLD; REPRODUCIBILITY; RETINOPATHY; SKIN ELECTRODE; SKIN FISSURE; SWEAT; SWEAT GLAND DISEASE; SWEATING;

DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSORY THRESHOLDS; SEVERITY OF ILLNESS INDEX; SWEATING; VIBRATION;

EID: 83255187360     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2011.05.003     Document Type: Article

References (24)

1. Tesfaye S., Boulton A.J., Dyck P.J., Freeman R., Horowitz M., Kemper P., et al. Diabetic neuropathies: update on definition, diagnostic criteria, estimation of severity and treatments. Diabetes Care 2010, 33:2285-2293.
2. Peters E.J., Lavery L.A. Effectiveness of the diabetic foot risk classification system of the international working group on the diabetic foot. Diabetes Care 2001, 24:1442-1447.
3. Boulton J.M., Malik R.A., Arezzo J.C., Sosenko J.M. Diabetic somatic neuropathies. Diabetes Care 2004, 27:1458-1486.
4. Coppini D.V., Wellmer A., Weng C., Anand P., Sonksen P.H. The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds. J Clin Neurosci 2001, 8:520-524.
5. Sun P.C., Lin H.D., Joa S.H., Chan R.C., Kao M.J., Cheng C.K. Thermoregulatory sudomotor dysfunction and diabetic neuropathy develop in parallel in at-risk feet. Diabet Med 2008, 25:413-418.
6. Vinik A.I., Mitchell B.D., Masser R.E., Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003, 26:1553-1579.
7. Kärvestedt L., Mårtensson E., Grill V., Elofsson S., von Wendt G., Hamsten A., et al. The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden. J Diabetes Complications 2011, 25:97-106.
8. Tentolouris N., Marinou K., Kokotis P., Karanti A., Diakoumopoulou E., Katsilambros N. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med 2009, 26:302-305.
9. Illigens B.M., Gibbons C.H. Sweat testing to evaluate autonomic function. Clin Auton Res 2009, 19:79-87.
10. ®) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. J Diabetes Complications 2007, 21:353-358.
11. Mayaudon H., Miloche P.O., Bauduceau B. A new simple method to assess sudomotor function: interest in type 2 diabetes. Diabetes Metab 2010, 36:450-454.
12. Young M.J., Bredly J.L., Veves A., Boulton A.J. The prediction of diabetic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994, 17:557-560.
13. Treece K.A., MacFarlane R.M., Pound N., Game F.L., Jeffcoate W.J. Validation of a system of foot ulcer classification in diabetes mellitus. Diabet Med 2004, 21:987-991.
14. Ayoub H., Griveau S., Lair V., Brunswick P., Cassir M., Bedioui F. Electrochemical characterization of nickel electrodes in phosphate and carbonate electrolytes in view of assessing a medical diagnostic device for the detection of early diabetes. Electroanalysis 2010, 22:2483-2490.
15. Hubert D., Brunswick P., Calvet J.H., Dusser D., Fajac I. Abnormal electrochemical skin conductance in cystic fibrosis. J Cyst Fibros 2011, 10:15-20.
16. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986, 1:307-310.
17. The R Project for Statistical Computing. http://www.r-project.org/.
18. Sumner C.J., Sheth S., Comblath D.R., Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003, 60:108-111.
19. Grandinetti A., Chow D.C., Sletten D.M., Oyama J.K., Theriault A.G., Schatz I.J., et al. Impaired glucose tolerance is associated with postganglionic sudomotor impairment. Clin Auton Res 2007, 17:231-233.
20. Smith A.G., Russell J., Feldman E.L., Goldstein J., Peltier A., Smith S., et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006, 29:1294-1299.
21. Sun P.C., Lin H.D., Joa S.H., Ku Y.C., Chan R.C., Cheng C.K. Relationship of skin temperature to sympathetic dysfunction in diabetic at-risk feet. Diabetes Res Clin Pr 2006, 73:41-46.
22. Low P.A. Evaluation of sudomotor function. Clin Neurophysiol 2004, 115:1506-1513.
23. ® test: a visual indicator test for human diabetic neuropathy. Diabetologia 2008, 51:1046-1050.
24. Provitera V., Nolano M., Caporaso G., Stancanelli A., Santoro, Kennedy W.R. Evaluation of sudomotor function in diabetes using the dynamic sweat test. Neurology 2010, 74:50-56.